MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effect of pill box organizers with alarm on improvement of adherence to pharmacotherapy in patients with Parkinson’s disease: a pilot study

I. Straka, M. Minár, M. škorvánek, M. Grofik, J. Benetin, P. Valkovič (Bratislava, Slovakia)

Meeting: 2019 International Congress

Abstract Number: 356

Keywords: Dopaminergics, Parkinsonism

Session Information

Date: Monday, September 23, 2019

Session Title: Neuropharmacology

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To find out whether pill box organizers with alarm would improve the rate of adherence in non-adherent patients with Parkinson’s disease (PD) taking three and more daily doses of antiparkinsonian drugs, and whether the improvement of adherence to pharmacotherapy affects the clinical parameters.

Background: Non-adherence to pharmacotherapy in chronic disorders is a very important healthcare problem. In PD patients, it is associated with motor and non-motor complications and reduced quality of life (QoL). Therefore, improvement of adherence to pharmacotherapy is a challenge in routine clinical practice. Previous data about an effect of dosing devices in chronic disorders were inconsistent, and this issue has not been investigated in PD.

Method: We included 96 non-demented subjects with idiopathic PD. We used validated Slovak versions of questionnaires and scales: 8-Item Morisky Medication Adherence Scale (MMAS-8), the Parkinson’s Disease Questionnaire-8 (PDQ-8), Geriatric Depression Scale (GDS), Non-motor Symptom Assessment Scale for Parkinson’s Disease (NMSS), 9-Item Wearing-off Questionnaire (WOQ-9), MDS-UPDRS parts III and IV. In our pilot study, non-adherent patients (≥3 points in the MMAS-8) received a pill box organizer with alarm at baseline visit, and they underwent follow-up visit after 6 weeks. We used Student T-test to determine the effect of our intervention.

Results: We involved 40 patients with PD (26 males) with mean age of 66.6 ± 9.2 years, median of Hoehn &Yahr stage was 2.5 (range 1-4), an average number of daily doses of PD drugs was 5.3 ± 1.1 with average levodopa equivalent dose 1379.1 ± 542.9 mg. In the 6-week period, the pill box organizer with alarm had significant effect on the increasing the rate of adherence (MMAS-8, p < 0.001), and the trend in improving motor and non-motor fluctuations (WOQ-9, p = 0.058) was identified.

Conclusion: Complex therapeutic regimens are associated with lover adherence. It is necessary to develop devices for improving adherence. In non-adherent PD patients who take three and more daily doses of antiparkinsonian drugs, introduction of a pill box organizer with alarm seems to be a promising in improving the rate of adherence. Moreover, it may potentially contribute to an improvement or alleviation of motor and non-motor complications.

To cite this abstract in AMA style:

I. Straka, M. Minár, M. škorvánek, M. Grofik, J. Benetin, P. Valkovič. Effect of pill box organizers with alarm on improvement of adherence to pharmacotherapy in patients with Parkinson’s disease: a pilot study [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/effect-of-pill-box-organizers-with-alarm-on-improvement-of-adherence-to-pharmacotherapy-in-patients-with-parkinsons-disease-a-pilot-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effect-of-pill-box-organizers-with-alarm-on-improvement-of-adherence-to-pharmacotherapy-in-patients-with-parkinsons-disease-a-pilot-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley